Novo Nordisk says more than 246,000 people are now taking its weight-loss pill. CEO Mike Doustdar sits down with Bloomberg’s Katie Greifeld to discuss GLP-1 supply, pricing and the company’s lawsuit against Hims over alleged obesity drug copycats. (Source: Bloomberg)

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are TIAA Wealth Management’s Niladri Mukherjee, Quest Diagnostics’s Jim Davis, Baird’s Michael Ha, BD’s Tom Polen, Charles Schwab’s Kevin Gordon, Cox Automotive’s Stephanie Valdez Streaty, Hinge Health’s Daniel Perez, Philips’ Roy Jakobs, Willkie Farr & Gallagher’s Edward Best, and ESPN’s Patrick McEnroe. (Source: Bloomberg)